Skip to content

Analysis of the clinical features and prognostic factors of malignant cystic pulmonary nodules

Analysis of the clinical features and prognostic factors of malignant cystic pulmonary nodules

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101379
Enrollment
Unknown
Registered
2025-04-24
Start date
2023-11-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic lung cancer

Interventions

Cystic lung cancer group:None
Solid lung cancer group:None
Ground-glass lung cancer group:None

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.After surgery, the nodule was confirmed to be malignant in nature; 2.The patient is >= 18 years old; 3.Chest CT shows cystic changes.

Exclusion criteria

Exclusion criteria: 1.Those who use chemotherapy, immunotherapy, and targeted drugs for adjuvant therapy before surgery; 2.Those who did not have chest CT images in our hospital before surgery; 3.Those with poor respiratory control resulting in poor imaging image quality; 4.The patient's lung lesions are multiple; 5.Patients with a history of malignant tumors such as breast cancer, kidney cancer, liver cancer, prostate cancer and active tuberculosis; 6.Previous history of lung surgery.

Design outcomes

Primary

MeasureTime frame
Progressive disease;

Secondary

MeasureTime frame
Tumor size;Pathological type;

Countries

China

Contacts

Public ContactLonghua Sun

The First Affiliated Hospital of Nanchang University

18279110112@163.com+86 791 88695051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026